Free Trial

Landore Resources (LND) Competitors

Landore Resources logo
GBX 3.40
-0.05 (-1.45%)
(As of 11/1/2024 ET)

LND vs. AVO, FDP, TED, ZNWD, ARCM, GSP, ARS, 1SN, RMR, and PYX

Should you be buying Landore Resources stock or one of its competitors? The main competitors of Landore Resources include Advanced Oncotherapy (AVO), FD Technologies (FDP), Ted Baker (TED), Zinnwald Lithium (ZNWD), Arc Minerals (ARCM), Gensource Potash (GSP), Asiamet Resources (ARS), First Tin (1SN), Rome Resources (RMR), and PYX Resources (PYX).

Landore Resources vs.

Landore Resources (LON:LND) and Advanced Oncotherapy (LON:AVO) are both small-cap basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, community ranking, earnings, profitability, risk, media sentiment and valuation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Landore Resources
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Advanced Oncotherapy
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Landore Resources has a beta of -0.15, suggesting that its share price is 115% less volatile than the S&P 500. Comparatively, Advanced Oncotherapy has a beta of 0.06, suggesting that its share price is 94% less volatile than the S&P 500.

Advanced Oncotherapy's return on equity of -67.34% beat Landore Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Landore ResourcesN/A -207.95% -106.31%
Advanced Oncotherapy N/A -67.34%-11.73%

Advanced Oncotherapy received 122 more outperform votes than Landore Resources when rated by MarketBeat users. Likewise, 60.97% of users gave Advanced Oncotherapy an outperform vote while only 57.76% of users gave Landore Resources an outperform vote.

CompanyUnderperformOutperform
Landore ResourcesOutperform Votes
67
57.76%
Underperform Votes
49
42.24%
Advanced OncotherapyOutperform Votes
189
60.97%
Underperform Votes
121
39.03%

Landore Resources is trading at a lower price-to-earnings ratio than Advanced Oncotherapy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Landore ResourcesN/AN/A-£1.77M-£0.01-340.00
Advanced OncotherapyN/AN/A-£32.60M-£0.07-25.00

In the previous week, Landore Resources had 1 more articles in the media than Advanced Oncotherapy. MarketBeat recorded 1 mentions for Landore Resources and 0 mentions for Advanced Oncotherapy. Advanced Oncotherapy's average media sentiment score of 0.00 beat Landore Resources' score of -0.78 indicating that Advanced Oncotherapy is being referred to more favorably in the news media.

Company Overall Sentiment
Landore Resources Negative
Advanced Oncotherapy Neutral

3.2% of Landore Resources shares are owned by institutional investors. Comparatively, 17.8% of Advanced Oncotherapy shares are owned by institutional investors. 39.6% of Landore Resources shares are owned by company insiders. Comparatively, 47.5% of Advanced Oncotherapy shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Advanced Oncotherapy beats Landore Resources on 9 of the 12 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LND vs. The Competition

MetricLandore ResourcesOther Industrial Metals & Mining IndustryMaterials SectorLON Exchange
Market Cap£10.64M£915.74M£3.06B£1.60B
Dividend Yield6.74%6.23%5.11%10.93%
P/E Ratio-340.0083.94125.191,755.31
Price / SalesN/A59,031.85544,039.52232,682.53
Price / Cash21.0024.1723.8436.19
Price / Book3.402.703.662.88
Net Income-£1.77M£56.87M£152.21M£145.32M
7 Day Performance-4.23%-1.08%-1.22%0.11%
1 Month Performance-8.11%1.70%1.87%-0.11%
1 Year Performance-54.97%35.86%32.78%15.48%

Landore Resources Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LND
Landore Resources
N/AGBX 3.40
-1.4%
N/A-55.5%£10.64MN/A-340.006
AVO
Advanced Oncotherapy
N/AGBX 1.75
-9.1%
N/A+0.0%£9.50MN/A-25.003,900Gap Down
FDP
FD Technologies
N/AGBX 1,735.33
+0.7%
N/A+105.1%£489.71M£248.86M-3,615.2840,100Gap Down
TED
Ted Baker
N/AGBX 109.80
flat
N/A+0.0%£202.71M£428.24M-5.69740
ZNWD
Zinnwald Lithium
N/AGBX 8.38
+2.0%
N/A-6.3%£39.74MN/A-825.0023Gap Down
ARCM
Arc Minerals
N/AGBX 1.95
-6.0%
N/A-48.1%£28.28MN/A-307.5035
GSP
Gensource Potash
N/AGBX 5.25
flat
N/AN/A£23.61MN/A-525.00N/A
ARS
Asiamet Resources
N/AGBX 0.80
+1.0%
N/A-23.1%£20.72MN/A-4.67N/A
1SN
First Tin
N/AGBX 6.50
+3.6%
N/A+35.9%£20.71MN/A-650.0027Positive News
RMR
Rome Resources
N/AGBX 0.42
+8.6%
N/AN/A£20.36MN/A0.00N/AHigh Trading Volume
PYX
PYX Resources
N/AGBX 4
-4.1%
N/AN/A£18.47M£21.43M-325.0095Gap Down
High Trading Volume

Related Companies and Tools


This page (LON:LND) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners